Category: Mindray Medical International Ltd.
Mindray Medical misses 1st-quarter revenue numbers, sending shares down 6.8% on Wall Street before recovering to pre-earnings levels
China is a huge potential medical device market and companies who can focus on value may in fact be the ones best-positioned for growth.
by Stephen D. Simpson, CFA
Masimo Corp. accuses its erstwhile partner, Mindray Medical, of patent infringement and breach of contract.
Mindray Medical's anesthesia delivery systems recall gets Class I status from the FDA over concerns that a defect that could lead to a gasket leak could harm patients.
The FDA slapped Mindray Medical's (NYSE:MR) anesthesia delivery system recall with Class I status after the federal watchdog agency deemed a gasket leak in the devices a potential hazard to patients.
Although there have been no reported injuries associated with the gasket leak, the FDA warned that the defect could reasonably cause patients harm.
Mindray Medical recalls its A3 and A5 anesthesia delivery systems over concerns that improper seating of the CO2 absorbent canister may result in leaking gas.
Mahwah, N.J.-based medical device maker Mindray Medical (NYSE:MR) recalled its A3 and A5 anesthesia delivery systems after a customer reported a system leak to the company.
Human Services Secretary Kathleen Sebelius may stay in the position for another term in order to follow through on implementation of President Barack Obama's healthcare reform laws.
HHS's Sebelius may stay for another term
Human Services Secretary Kathleen Sebelius might stay for a 2nd term, which would be unusual for someone in that position, according to a Kaiser Health News report.
A comparison of asset values and share values for medical device companies from the MassDevice Big 100 database.
One way to assess stock values is to compare the stock's share price with its asset value.
The latter is the number of shares outstanding divided into total assets. When the result is compared with share prices, it can help investors decide whether a stock is over- or under-valued.
We took a look at the asset values for 15 of the world's largest pure-play medical device companies and then compared them with the companies' stock price.